Keep track of your progress

Keep track of your progress

It can be tricky to see how much things change over time if you haven’t kept a record. Think about how you were feeling two weeks ago. Do you remember what your mood was like, if there was anything you felt you couldn’t do because of your PsA (psoriatic arthritis) symptoms, what kind of pain did you have and where? Having this information and more could really help your healthcare professional see how you’re doing, and whether anything, including your treatment, might need to change.[1][2]

basketball
TOP TIP
“I know there are always options now no matter how bad it gets.”*

Things to think about every day that could help you keep track of your progress:[1][3]

  • What’s your mood like?
  • How painful are your PsA symptoms?
  • Where are your PsA symptoms?
  • Has your PsA stopped you doing anything today?
  • Did you have trouble sleeping last night because of your PsA?
  • Have you used any PsA treatment today?
  • Have you felt any side effects from your treatment today? If yes, what did you experience?
  • Have you taken any other medicine today? If yes, what have you taken?
  • Have you noticed anything that triggers your PsA symptoms? If yes, what do you think it was?

Having answers to questions like the ones above could be a valuable conversation starter when speaking to your doctor, but please remember it doesn’t take the place of a medical assessment.

You may be interested in

How to get moving

Exercise could help you manage your psoriatic arthritis.

What could the future hold?

Does psoriatic arthritis (PsA) always stay the same?

How to prepare to see your doctor

Make every moment of the consultation really count.

*Representative of patient experience

References

National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. 2014. CG178.
APA Clinical Guidelines. American Psychiatric Association. Practice Guidelines for the treatment of patients with schizophrenia. 2004.
Harrigan et al. Psychol Med 2003; 33: 97–110.
Bottlender et al. Schizophr Res 2003; 62: 37–44.
Weiden et al. Psychiatr Serv 2004; 55: 886–891.
Robinson et al. Arch Gen Psychiatry 1999; 56: 241–247.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson